EGM
SNDX icon

Engineers Gate Manager’s Syndax Pharmaceuticals SNDX Stock Holding History

Engineers Gate Manager’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$897K Buy
38,408
+12,143
+46% +$264K 0.01% 1105
2025
Q4 		$552K Sell
26,265
-153,101
-85% -$2.67M 0.01% 1309
2025
Q3 		$2.76M Buy
179,366
+90
+0.1% +$1.18K 0.03% 610
2025
Q2 		$1.68M Buy
179,276
+52,791
+42% +$581K 0.02% 829
2025
Q1 		$1.55M Sell
126,485
-21,188
-14% -$299K 0.03% 815
2024
Q4 		$1.95M Buy
147,673
+88,262
+149% +$1.51M 0.03% 638
2024
Q3 		$1.14M Sell
59,411
-16,429
-22% -$339K 0.02% 909
2024
Q2 		$1.56M Buy
75,840
+33,353
+79% +$698K 0.04% 680
2024
Q1 		$1.01M Buy
42,487
+26,247
+162% +$585K 0.03% 819
2023
Q4 		$351K Sell
16,240
-54,296
-77% -$835K 0.01% 1367
2023
Q3 		$1.02M Buy
70,536
+9,793
+16% +$185K 0.04% 695
2023
Q2 		$1.27M Buy
60,743
+9,318
+18% +$194K 0.05% 551
2023
Q1 		$1.09M Buy
+51,425
New +$1.28M 0.05% 581
2022
Q2 		– Sell
-40,804
Closed -$709K – 2235
2022
Q1 		$709K Buy
40,804
+17,506
+75% +$295K 0.03% 875
2021
Q4 		$510K Buy
+23,298
New +$430K 0.02% 1042
2021
Q3 		– Sell
-16,609
Closed -$285K – 1952
2021
Q2 		$285K Sell
16,609
-6,759
-29% -$124K 0.02% 1171
2021
Q1 		$523K Buy
23,368
+5,552
+31% +$125K 0.03% 967
2020
Q4 		$396K Buy
+17,816
New +$369K 0.02% 1126

Other funds holding SNDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Engineers Gate Manager's SNDX Position: Q1 2026 in Review

Engineers Gate Manager increased its Syndax Pharmaceuticals (SNDX) stake by 46% in Q1 2026, buying an estimated $264K and bringing the position to 38,408 shares worth $897K. The position accounts for 0.01% of the portfolio, ranked #1105.

Engineers Gate Manager first reported a position in SNDX in Q4 2020 and has held it in 18 quarters since. The position peaked at $2.76M in Q3 2025. 246 funds tracked by Wall St. Rank hold SNDX as of Q1 2026.

  • Engineers Gate Manager held 38,408 shares of Syndax Pharmaceuticals worth $897K as of Q1 2026.
  • Engineers Gate Manager bought 12,143 Syndax Pharmaceuticals shares in Q1 2026, an estimated $264K.
  • Syndax Pharmaceuticals made up 0.01% of Engineers Gate Manager's portfolio in Q1 2026, its #1105 holding.
  • Engineers Gate Manager first reported a position in Syndax Pharmaceuticals in Q4 2020 and has held it in 18 quarters since.
  • Engineers Gate Manager's Syndax Pharmaceuticals position peaked at $2.76M in Q3 2025.
  • 246 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q1 2026.

Based on Engineers Gate Manager's 13F filing for Q1 2026, filed 15 May 2026.